Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
HUGH M. JONES
Observed names:
Hugh Jones,
Hugh M Jones,
Hugh M. Jones
Institution:
King's College London
Observed institutions:
King's College London,
South London and Maudsley NHS Foundation Trust,
Homerton University Hospital,
Homerton University Hospital NHS Foundation Trust,
Maudsley Hospital
OpenAlex ID:
A5111763281
Is Regionally Selective D2/D3 Dopamine Occupancy Sufficient for Atypical Antipsychotic Effect? An In Vivo Quantitative [123I]Epidepride SPET Study of Amisulpride-Treated Patients
2003
·
Rodrigo A. Bressan
, Kjell Erlandsson
, et al.
·
American Journal of Psychiatry
·
128
Semantic Organization and Verbal Memory Efficiency in Patients With Schizophrenia.
2004
·
Gildas Brébion
, Anthony S. David
, et al.
·
Neuropsychology
·
99
Typical antipsychotic drugs — D2 receptor occupancy and depressive symptoms in schizophrenia
2002
·
Rodrigo A Bressan
, Durval C Costa
, et al.
·
Schizophrenia Research
·
90
Optimizing Limbic Selective D2/D3 Receptor Occupancy by Risperidone: A [123I]-Epidepride SPET Study
2003
·
Rodrigo A. Bressan
, Kjell Erlandsson
, et al.
·
Journal of Clinical Psychopharmacology
·
79
Cortical effects of quetiapine in first-episode schizophrenia: A preliminary functional magnetic resonance imaging study
2004
·
Hugh M. Jones
, Michael J. Brammer
, et al.
·
Biological Psychiatry
·
55
Hallucinations, Negative Symptoms, and Response Bias in a Verbal Recognition Task in Schizophrenia.
2005
·
Gildas Brébion
, Anthony S. David
, et al.
·
Neuropsychology
·
52
Atypical antipsychotic drugs and tardive dyskinesia: relevance of D2 receptor affinity
2004
·
Rodrigo A. Bressan
, Hugh M. Jones
, et al.
·
Journal of Psychopharmacology
·
40
Temporal context discrimination in patients with schizophrenia: Associations with auditory hallucinations and negative symptoms
2006
·
Gildas Brébion
, Anthony S. David
, et al.
·
Neuropsychologia
·
39
In vivo 5-HT 2A receptor blockade by quetiapine
2001
·
Hugh Jones
, Michael Travis
, et al.
·
Psychopharmacology
·
39
Visual memory errors in schizophrenic patients with auditory and visual hallucinations
2007
·
GILDAS BRÉBION
, ANTHONY S. DAVID
, et al.
·
Journal of the International Neuropsychological Society
·
29
Clinical effectiveness in first-episode patients
2004
·
Ruth I. Ohlsen
, Mary S. O'Toole
, et al.
·
European Neuropsychopharmacology
·
28
Working Memory Span and Motor and Cognitive Speed in Schizophrenia
2009
·
Gildas Brébion
, Anthony S. David
, et al.
·
Cognitive and Behavioral Neurology
·
27
Recognition of Visual Stimuli and Memory for Spatial Context in Schizophrenic Patients and Healthy Volunteers
2004
·
Gildas Brébion
, Anthony S. David
, et al.
·
Journal of Clinical and Experimental Neuropsychology
·
16
New targets for antipsychotics
2002
·
Hugh M Jones
, Lyn S Pilowsky
·
Expert Review of Neurotherapeutics
·
13
Neuroendocrine Evidence That Clozapine's Serotonergic Antagonism Is Relevant to Its Efficacy in Treating Hallucinations and Other Positive Schizophrenic Symptoms
1998
·
Hugh Jones
, Vivienne A. Curtis
, et al.
·
American Journal of Psychiatry
·
13
Risperidone is associated with blunting of D-fenfluramine evoked serotonergic responses in schizophrenia
1998
·
Hugh Jones
, Vivienne A. Curtis
, et al.
·
International Clinical Psychopharmacology
·
11
Dopamine D2 Receptor Blockade in Schizophrenia
2001
·
RODRIGO A. BRESSAN
, HUGH M. JONES
, et al.
·
American Journal of Psychiatry
·
10
In Vivo Serotonin 5-HT2A Receptor Occupancy and Quetiapine
2000
·
HUGH M. JONES
, MICHAEL J. TRAVIS
, et al.
·
American Journal of Psychiatry
·
10
On Biology, Phenomenology, and Pharmacology in Schizophrenia
2004
·
HUGH M. JONES
·
American Journal of Psychiatry
·
4
d-Fenfluramine-evoked serotonergic responses in olanzapine-treated schizophrenic patients
2002
·
Hugh Jones
, Vivienne A Curtis
, et al.
·
Psychiatry Research
·
3
Review of College guidelines on high-dose neuroleptic use in a psychiatric intensive care unit
1998
·
Hugh Jones
, Rachel Jones
, et al.
·
Psychiatric Bulletin
·
3
PDF
Do selective serotonin reuptake inhibitors cause suicide?: Discrediting old drugs may be useful in marketing new ones
2005
·
Hugh M Jones
·
BMJ
Show more works
View as search
Works count:
22
Citation count:
788
H-index:
13
I10-index:
18
Year
Topic
Type